000403.SZ实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:04):

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China...

Stats
今日成交量	3.46M
平均成交量	5.61M
市值	21.75B
EPS	CNY0.250 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	38.79
ATR14	CNY0.0320 (0.11%)

音量相关性

長: 0.07 (neutral)

短: 0.85 (strong)

Signal:(63.153) Same movement expected

Pacific Shuanglin 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Pacific Shuanglin 相关性 - 货币/商品

0.03
( neutral )

-0.12
( neutral )

0.00
( neutral )

0.05
( neutral )

-0.35
( neutral )

-0.31
( neutral )

Pacific Shuanglin 财务报表

Annual	2023
营收:	CNY2.33B
毛利润:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2023
营收:	CNY2.33B
毛利润:	CNY2.33B (100.00 %)
EPS:	CNY0.840

FY	2022
营收:	CNY2.41B
毛利润:	CNY1.25B (52.13 %)
EPS:	CNY0.800

FY	2021
营收:	CNY1.97B
毛利润:	CNY908.43M (46.07 %)
EPS:	CNY0.554

Financial Reports:

No articles found.

Pacific Shuanglin

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.